Clinico-Radiological Features and Outcomes in Pregnant Women with COVID-19 Pneumonia Compared with Age-Matched Non-Pregnant Women
GHDx Entry last modified on: Mar 14, 2022
COVID-19
Dataset Records for COVID-19
Displaying 1001 - 1050 of 1372
Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App
GHDx Entry last modified on: Apr 10, 2023
Maternal and neonatal outcomes in COVID-19 infected pregnancies: a prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Canada - Daily Epidemiologic Summary of COVID-19 in Ontario 2020
Epidemiologic Summary COVID-19 in Ontario
Higher SARS-CoV-2 Infection Rate in Pregnant Patients
GHDx Entry last modified on: Jan 31, 2024
[Assessment of population immunity to SARS-CoV-2 among the population of the Leningrad region during the COVID-19 epidemic]
Оценкa популяционого имм унитета к SARS-CoV-2 среди населения Ленинградск ой области в период эпидемии COVID-19
Author Correction: A global survey of potential acceptance of a COVID-19 vaccine
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1)
GHDx Entry last modified on: Jun 17, 2021
Global COVID-19 Routine Childhood Vaccination Disruption 2020
GHDx Entry last modified on: Feb 5, 2024
Performance of rapid IgM-IgG combined antibody tests in the occupational surveillance of COVID-19 in Colombian enterprises
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
GHDx Entry last modified on: Jan 31, 2024
A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Prevalence among Outpatients during Community Transmission, Zambia, July 2020
GHDx Entry last modified on: Mar 14, 2022
Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea
GHDx Entry last modified on: Mar 14, 2022
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients
GHDx Entry last modified on: Apr 10, 2023
Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands
GHDx Entry last modified on: May 12, 2022
Reassessing the population based Seroprevalence for IgG antibodies against SARS COV2 in Ahmedabad
GHDx Entry last modified on: Jan 31, 2024
Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study
GHDx Entry last modified on: Apr 10, 2023
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
GHDx Entry last modified on: Mar 14, 2022
Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic
GHDx Entry last modified on: Mar 14, 2022
Body Composition in Community-Dwelling Older Adults Before and After SARS-CoV-2 Infection: A Longitudinal Prospective Study in a Rural Village Struck by the Pandemic
GHDx Entry last modified on: Mar 14, 2022
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020
GHDx Entry last modified on: Jan 31, 2024
Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey
GHDx Entry last modified on: Feb 29, 2024
United Kingdom - England and Wales Deaths Registered Weekly 2022
Deaths registered weekly in England and Wales, provisional
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals. Preprint
GHDx Entry last modified on: Apr 14, 2022
Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City
GHDx Entry last modified on: Jan 31, 2024
Initial findings of universal screening for SARS-CoV-2 in women admitted for delivery in North Wales: a prospective multicentre cohort study
GHDx Entry last modified on: Jan 31, 2024
Coronavirus disease 2019 infection and placental histopathology in women delivering at term
GHDx Entry last modified on: Jan 31, 2024
Maternal death due to COVID-19
GHDx Entry last modified on: Apr 10, 2023
Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
GHDx Entry last modified on: Mar 22, 2024
Fatigue and quality-of-life in the year following SARS-Cov2 infection
GHDx Entry last modified on: Mar 22, 2024
Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months
GHDx Entry last modified on: Mar 22, 2024
Sri Lanka Epidemiology Unit Coronavirus Disease 2019 (COVID-19) Situation Report 2020-2022
Coronavirus disease 2019 (COVID-19) - Situation Report
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
GHDx Entry last modified on: Mar 14, 2022
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states. Preprint
Scientific literature:
Household
Seroprevalence of COVID-19 in Niger State. Preprint
GHDx Entry last modified on: Mar 4, 2024
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort
GHDx Entry last modified on: Jan 31, 2024
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
GHDx Entry last modified on: Jan 31, 2024
Persistent Symptoms in Patients After Acute COVID-19
GHDx Entry last modified on: Apr 10, 2023
Racial-ethnic disparities and pregnancy outcomes in SARS-CoV-2 infection in a universally-tested cohort in Houston, Texas
GHDx Entry last modified on: Jan 31, 2024
A snapshot of the Covid-19 pandemic among pregnant women in France
GHDx Entry last modified on: Mar 14, 2022
[The experience of the study of seroprevalence to the SARS-CoV-2 virus in the population of the Irkutsk region during the COVID-19 outbreak]
Опыт исс ледования серопревалентности к вирусу SARS-CoV-2 населения Иркутск ой области в период вспышки COVID-19
Brazil - Severe Acute Respiratory Syndrome Database - including data from COVID-19 2020-2022
Severe Acute Respiratory Syndrome Database - including COVID-19 data
Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study. Preprint
GHDx Entry last modified on: Sep 21, 2021
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Lithuania: Results of National Population Survey. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Subscribe